In addition, the pan-caspase inhibitor emricasan can inhibit the PANoptosis induced by co-treatment of IFN-γ and TNF-α and reduce cell death in DNA mismatch repair deficiency (dMMR) tumor [107]. The gene discussed is TNF; the disease is neoplasm.